Log In
Print
BCIQ
Print
Print this Print this
 

OX51

  Manage Alerts
Collapse Summary General Information
Company Orexo AB
DescriptionSublingual tablet formulation of alfentanil
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsPrevent procedure-induced pain
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today